• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

R.A.C.E. To Diagnose ALS/MND

A Call to Action to Refer Early Across Diverse Healthcare Settings

 

    This project was initiated and funded by My Name’5 Doddie Foundation.   

Learning Objectives

  • Recognize the early signs and symptoms of ALS/MND across diverse healthcare settings and specialties
  • Assess clinical features and initiate appropriate investigations (if warranted) without delaying referral
  • Communicate the need for an urgent onward specialist referral to those with suspected ALS/MND
  • Expedite referrals — even in the absence of complete diagnostic confirmation — and ensure referral letters clearly communicate key clinical findings to support triage

Resources

  • Content
  • Evaluation Form
  • Invitation Live Event
  • Invitation Virtual Event
  • Participant Handout
  • Speaker Guide
  • Certificate (with speaker)
  • Certificate

Videos

Person Living with ALS/MND Sharing His Diagnostic Journey

Mr. Craig Reyenga,

Craig Reyenga, a person living with ALS/MND, shares his challenging diagnostic journey and the difficulties he faced throughout the process.

https://www.als-mnd.org/wp-content/uploads/2026/02/craig_reyenga´s_als_mnd_diagnosis_story_v1-1080p.mp4

Overcoming Therapeutic Nihilism in ALS/MND

Prof. Orla Hardiman, BSc, MB, MD, FRCPI, FTCD, MRIA

Prof. Hardiman addresses the misconception that ALS/MND referrals are futile, stressing that multidisciplinary clinics significantly improve quality of life, offer access to research and emerging therapies, and provide meaningful hope for patients.

https://www.als-mnd.org/wp-content/uploads/2026/02/orla_hardiman_-_overcoming_therapeutic_nihilism_v1-720p.mp4

The Cost of Delayed Diagnosis: Personal Stories from the Faculty

Members of the faculty present cases they have encountered that highlight the real-world impact of diagnostic delays in ALS/MND.

Prof. Orla Hardiman, BSc, MB, MD, FRCPI, FTCD, MRIA

https://www.als-mnd.org/wp-content/uploads/2026/02/video_orla_hardiman_-_the_cost_of_delayed_diagnosis__personal_stories_from_the_faculty_v1-720p.mp4

Ms. Marla Calder, BScOT

https://www.als-mnd.org/wp-content/uploads/2026/02/marla_calder_–_the_cost_of_delayed_diagnosis__personal_stories_from_the_faculty_v1-720p.mp4

Prof. Christopher J. McDermott, PhD, MD, FRCP

https://www.als-mnd.org/wp-content/uploads/2026/02/chris_mcdermott_–_the_cost_of_delayed_diagnosis__personal_stories_from_the_faculty_v1-720p.mp4

Prof. Nortina Shahrizaila, DM, PhD, FRCP 

https://www.als-mnd.org/wp-content/uploads/2026/02/nortina_shahrizaila_–_the_cost_of_delayed_diagnosis__personal_stories_from_the_faculty_v1-720p.mp4

RECAP: When to Suspect ALS/MND and Refer

Prof. Nortina Shahrizaila, DM, PhD, FRCP

Prof. Shahrizaila summarizes key red flags for ALS/MND, such a progressive, painless loss of motor function or unexplained weight loss with breathing difficulty, and emphasizes the need for immediate referral when symptoms do not fit typical patterns.

https://www.als-mnd.org/wp-content/uploads/2026/02/nortina_shahrizaila_-_recap__when_to_suspect_als_mnd_and_refer_v1-720p.mp4

Avoid Diagnostic Pitfalls: Prioritize Urgent Referrals

Prof. Orla Hardiman, BSc, MB, MD, FRCPI, FTCD, MRIA

Prof. Hardiman advises non-specialists to refer suspected ALS/MND cases promptly rather than ordering exhaustive tests, noting that early referral prevents delays, reduces unnecessary costs, and ensures patients access specialized evaluation.

https://www.als-mnd.org/wp-content/uploads/2026/02/orla_hardiman_-_avoid_diagnostic_pitfalls__prioritize_urgent_referrals_v1-720p.mp4

Craig’s MRI Maze: A Journey Through Missed Opportunities and Delayed Referral

Mr. Craig Reyenga

Craig Reyenga reflects on his prolonged diagnostic process and how delays left him uncertain about how to live his life and plan for the future, wishing he had been referred to a specialist sooner.

https://www.als-mnd.org/wp-content/uploads/2026/02/craig_reyenga_-_a_journey_through_missed_opportunities_and_delayed_referral_v1-720p.mp4

Faculty Perspective: Frustration with Referral Delays

Prof. Christopher J. McDermott, PhD, MD, FRCP

Prof. McDermott discusses the frustration of receiving late referrals for ALS/MND patients, emphasizing how waiting for diagnostic certainty delays care, support, and access to clinical trials. He urges clinicians to refer early if ALS/MND is even a possibility.

https://www.als-mnd.org/wp-content/uploads/2026/02/chris_mcdermott_–_frustration_with_referral_delays_v1-720p.mp4

From Diagnostic Uncertainty to Clarity: Insights from the Voices of People Living with ALS/MND

Two people living with ALS/MND share their journey, describing the impact of not having a diagnosis and how they felt once it was confirmed.

Ms. Leanne Sklavenitis

https://www.als-mnd.org/wp-content/uploads/2026/03/ALALS2501-video-de-Leanne-v3.mp4

Mr. Bruce Virgo

https://www.als-mnd.org/wp-content/uploads/2026/03/ALALS2501-Bruce-video-v5-1.mp4

What If the Patient Asks: “Could this be ALS/MND?”

Ms. Marla Calder, BScOT

Marla Calder explains how allied health professionals should respond when patients raise concerns about serious conditions—by being honest, supportive, and ensuring prompt referral and clear documentation rather than attempting to diagnose.

https://www.als-mnd.org/wp-content/uploads/2026/02/marla_calder_–_what_if_the_patient_asks__could_this_be_als_mnd__v1-720p.mp4

 

For additional information or enquiries on booking the faculty, please email education@als-mnd.org.

Primary Sidebar

  • Frank "Papa" Taylor, USA

    Frank “Papa” Taylor, USA

  • Enzo Maccarrone, AISLA ONLUS, Italy

    Enzo Maccarrone, AISLA ONLUS, Italy

  • Juvenal Bayona Romero

    Juvenal Bayona Romero

  • Hans Dieter Olszewski, Diagnosed 2010 , DGM, Germany

    Hans Dieter Olszewski, Diagnosed 2010 , DGM, Germany

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Lin Yong Yi, Taiwan MND Association, Diagnosed 2004

    Lin Yong Yi, Taiwan MND Association, Diagnosed 2004

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Fabio Carvalho, Associação Pró-Cura da ELA, Brazil

    Fabio Carvalho, Associação Pró-Cura da ELA, Brazil

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Chris McCauley, Diagnosed 2015 , ALS Canada

    Chris McCauley, Diagnosed 2015 , ALS Canada

  • Zabun Nassar, MND Association, Diagnosed 2016, England

    Zabun Nassar, MND Association, Diagnosed 2016, England

  • Mary Thomas, Diagnosed 2013 , MND Australia

    Mary Thomas, Diagnosed 2013 , MND Australia

  • Natalya Rybakova, Russian Charity ALS Foundation

    Natalya Rybakova, Russian Charity ALS Foundation

  • Susan Keldani, Les Turner ALS Foundation, USA

    Susan Keldani, Les Turner ALS Foundation, USA

  • IMG_1211

    IMG_1211

  • Liam Dwyer, England

    Liam Dwyer, England

  • Xian-Zhang Niu, Diagnosed 2006 , Shaanxi ALS Association, China

    Xian-Zhang Niu, Diagnosed 2006 , Shaanxi ALS Association, China

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Eddy LeFrançois, Diagnosed 1992,  ALS Canada

    Eddy LeFrançois, Diagnosed 1992, ALS Canada

  • Camilla Heiberg Freiberg, Muskelsvindfonden, Denmark

    Camilla Heiberg Freiberg, Muskelsvindfonden, Denmark

  • Mike Small, Motor Neurone Disease (MND) Association, UK

    Mike Small, Motor Neurone Disease (MND) Association, UK

  • Conny van der Meijden, Diagnosed 2001,  ALS Netherlands

    Conny van der Meijden, Diagnosed 2001, ALS Netherlands

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Cath Muir

    Cath Muir
    Cath

  • Danny Reviers, Diagnosed 1979 , ALS Liga België, Belgium

    Danny Reviers, Diagnosed 1979 , ALS Liga België, Belgium

  • Ian and Teresa Roberts

    Ian and Teresa Roberts

  • Duncan Bayly , MND Australia

    Duncan Bayly , MND Australia

  • Dr Shelly Hoover

    Dr Shelly Hoover

  • Rosie Riley, Les Turner ALS Foundation, USA

    Rosie Riley, Les Turner ALS Foundation, USA

  • Ali Var, Turkey

    Ali Var, Turkey

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Bjarne Hytjanstorp, ALS Norge, Norway

    Bjarne Hytjanstorp, ALS Norge, Norway

  • Feng Gin Sun, Diagnosed 2014 , Shaanxi ALS Association, China

    Feng Gin Sun, Diagnosed 2014 , Shaanxi ALS Association, China

  • Bob Simonds and Drew O'Neil, USA

    Bob Simonds and Drew O’Neil, USA

  • Sébastien Batiot, Diagnosed 2012 , ARSLA, France

    Sébastien Batiot, Diagnosed 2012 , ARSLA, France

  • Mauril Bélanger, Diagnosed 2015 , ALS Canada

    Mauril Bélanger, Diagnosed 2015 , ALS Canada

  • Ailsa Malcolm-Hutton, Diagnosed 2013,  MND Association of England, Wales and N Ireland

    Ailsa Malcolm-Hutton, Diagnosed 2013, MND Association of England, Wales and N Ireland

  • Joyce Rusinak, Forbes Norris ALS Center, USA

    Joyce Rusinak, Forbes Norris ALS Center, USA

  • Norm MacIsaac,  ALS Society of Canada,  ALS Society of Quebec,  Diagnosed 2014

    Norm MacIsaac, ALS Society of Canada, ALS Society of Quebec, Diagnosed 2014

  • Elkin Ramiro Gaviria Muñoz, Diagnosed December 2018

    Elkin Ramiro Gaviria Muñoz, Diagnosed December 2018

  • Michel Perrozzo, ARSLA, Diagnosed 2015, France

    Michel Perrozzo, ARSLA, Diagnosed 2015, France

  • Mike Rannie,  ALS Canada,  Diagnosed 2017

    Mike Rannie, ALS Canada, Diagnosed 2017

  • Alfredo Santos, Diagnosed 2013 , ACELA, Colombia

    Alfredo Santos, Diagnosed 2013 , ACELA, Colombia

  • David Bishop

    David Bishop

  • Liz Ogg, Diagnosed 2013 , MND Scotland, UK

    Liz Ogg, Diagnosed 2013 , MND Scotland, UK

  • Richard Clark, MND New Zealand,  Diagnosed 2011

    Richard Clark, MND New Zealand, Diagnosed 2011

  • Yessenia Hernandez Mendoza, Apoyo Integral Gila A.C., Diagnosed 2018, Mexico

    Yessenia Hernandez Mendoza, Apoyo Integral Gila A.C., Diagnosed 2018, Mexico

  • Claudia Cominetti, Associazione conSLAncio Onlus,  Italy

    Claudia Cominetti, Associazione conSLAncio Onlus, Italy

  • 83

    83

Learn more about the March of Faces

Footer

Subscribe to our Bi-monthly Newsletter

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login